Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors
Tau hyperphosphorylation is one hallmark of Alzheimer's disease (AD) pathology. Pharmaceutical companies have thus developed kinase inhibitors aiming to reduce tau hyperphosphorylation. One obstacle in screening for tau kinase inhibitors is the low phosphorylation levels of AD-related phospho-e...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386519/ |